Oral therapy of recombinant Subtilisin QK-2 potentiates thrombolytic effect in a carrageenan-induced thrombosis animal model

Oral therapy of recombinant Subtilisin QK-2 potentiates thrombolytic effect in a carrageenan-induced thrombosis animal model

Thrombosis is a severe health care issue and one of the leading causes of death globally. Since presently used drugs have a number of limitations, safe and effective thrombolytic agents are still needed. Subtilisin QK, widely used as a component of functional food, presents high direct cross-linked...

Full description

Bibliographic Details
Main Authors:	Yiping Tang, Yuanyuan Yang, Xuan Lu, Qiuchen Liu, Qiaohong Li, Xia Song, Man Wang, Hankun Hu, Li Zhou, Yefu Wang
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of Functional Foods
Subjects:	Recombinant Subtilisin QK-2 Thrombosis Fibrinolysis Thrombolysis D-dimer Fibrin/fibrinogen degradation products (FDPs)
Online Access:	http://www.sciencedirect.com/science/article/pii/S1756464621005454

Similar Items

Quantification of Plasma Fibrinogen Degradation Products in Areca Nut Chewers with and without Oral Submucous Fibrosis
by: Sonia Gupta, et al.
Published: (2014-11-01)

Nattokinase historical sketch on experimental and clinical evidence
by: Pierpaolo Di Micco, et al.
Published: (2023-05-01)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
by: Thembaninkosi G. Gaule, et al.
Published: (2021-06-01)

Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus
by: Rustem I. Litvinov, et al.
Published: (2019-07-01)

Ca(2+)-dependent regulation of fibrinolytic system activation on fibrin(ogen) D-domains
by: T. A. Yatsenko, et al.
Published: (2017-10-01)

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
by: Jason S. Palazzolo, et al.
Published: (2022-07-01)

Fibrinolysis in Dogs with Intracavitary Effusion: A Review
by: Andrea Zoia, et al.
Published: (2022-09-01)

Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies
by: Ryuta NAKAE, et al.
Published: (2022-06-01)

Validation of the diagnostics algorithm to monitor coagulation parameters in pregnant women
by: D. S. Korolova, et al.
Published: (2023-06-01)

Spectrophotometric analysis of thrombolytic activity: SATA assay
by: Masumeh Zamanlu, et al.
Published: (2018-01-01)

Functional properties of individual sub-domains of the fibrin(ogen) αC-domains
by: Y.M. Stohnii, et al.
Published: (2023-01-01)

Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy?
by: Brian S. Bull, et al.
Published: (2022-04-01)

Thrombolytic Enzymes of Microbial Origin: A Review
by: Deepti Diwan, et al.
Published: (2021-09-01)

Interaction of hementin with fibrinogen and fibrin /
by: 236439 Budzynski, A. Z.

Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders
by: Richard J. Fish, et al.
Published: (2021-01-01)

SMTP (<it>Stachybotrys microspora </it>triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats
by: Hu Weimin, et al.
Published: (2012-01-01)

Identification of the binding site for plasminogen kringle 5 in the α-chain of fibrin(ogen) D-fragment
by: L. G. Kapustianenko, et al.
Published: (2020-06-01)

Two Novel and Three Recurrent Mutations in the Mevalonate Pathway Genes in Chinese Patients with Porokeratosis
by: Wang X, et al.
Published: (2024-01-01)

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis
by: Vassilios P. Memtsas, et al.
Published: (2021-02-01)

Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
by: Rajni Singh, et al.
Published: (2023-11-01)

Overall hemostasis potential of the blood plasma and its relation to some molecular markers of the hemostasis system in patients with chronic renal disease of stage VD
by: B. G. Storozhuk, et al.
Published: (2018-11-01)

The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis
by: Claire S. Whyte, et al.
Published: (2022-03-01)

Randomized Comparative Study of the Effects of Treatment with Once-Daily, Niacin Extended-Release/Lovastatin and with Simvastatin on Lipid Profile and Fibrinolytic Parameters in Taiwan
by: Tsung-Hsien Lin, et al.
Published: (2006-06-01)

Molecular Detection of Venous Thrombosis in Mouse Models Using SPECT/CT
by: Annemiek Dickhout, et al.
Published: (2022-06-01)

Efficacy of Coagulofibrinolytic Markers for Postoperative Prediction of Venous Thromboembolism in Colorectal Surgery Patients: A Retrospective Observational Study
by: Hironori Matsumoto, et al.
Published: (2023-07-01)

Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase
by: Feng Huang, et al.
Published: (2020-10-01)

Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
by: Zsuzsa Bagoly, et al.
Published: (2021-02-01)

Overall hemostasis potential of blood plasma and its connection to molecular markers of the hemostasis system in patients with stenosis of coronary artery
by: N. V. Storozhuk, et al.
Published: (2021-10-01)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
by: Nurul H. Sulimai, et al.
Published: (2022-07-01)

Subtilisin-Involved Morphology Engineering for Improved Antibiotic Production in Actinomycetes
by: Yuanting Wu, et al.
Published: (2020-06-01)

Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling
by: Parthasarathy Seshacharyulu, et al.
Published: (2022-01-01)

Effect of immobilized hyaluronidase and subtilisin enzymes on the ultrastructure of human conjunctival epithelial cells
by: V. E. Zabanova, et al.
Published: (2023-02-01)

The efficacy and safety of thrombolytic agents for patients with prosthetic valve thrombosis
by: Vinod Sharma, et al.
Published: (2022-01-01)

Unreliability of Serum‐ or Plasma‐based Assays of D‐dimer or Fibrin (Fibrinogen) Degradation Product for Diagnosing Periprosthetic Joint Infection: A Prospective Parallel Study
by: Hong Xu, et al.
Published: (2024-01-01)

Global coagulation assays in patients with diabetes mellitus
by: Hui Yin Lim, et al.
Published: (2021-10-01)

“Going with the flow” in modeling fibrinolysis
by: Claire S. Whyte, et al.
Published: (2022-12-01)

Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi
by: Anuj Narwal, et al.
Published: (2023-01-01)

Discussion on operation: To compare the curative effect of PMT and CDT in the treatment of middle and high risk stratified APE and the clinical application value of serum BNP, TnI and plasma DFR levelse
by: Qinglong Guan, et al.
Published: (2023-02-01)

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial
by: Gael B. Morrow, et al.
Published: (2022-09-01)

Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients
by: Jin T, et al.
Published: (2022-11-01)